![Keith Manchester](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Manchester
Direktor/Vorstandsmitglied bei
ROIVANT SCIENCES LTD.
Vermögen: 61 Mio $ am 31.08.2026
Profil
Keith S.
Manchester is currently an Independent Director at Roivant Sciences Ltd. since 2014, a Director at Roivant Sciences, Inc. since 2014, a Director at Kriya Therapeutics, Inc., and a Partner & Portfolio Manager at QVT Financial LP since 2005.
Former roles include Director at Resolvyx Pharmaceuticals, Inc., Director at Arbutus Biopharma, Inc. from 2014 to 2015, Director at Myovant Sciences Ltd. from 2016 to 2018, Independent Director at Montes Archimedes Acquisition Corp., Independent Director at Arbutus Biopharma Corp.
from 2015 to 2025, Vice President-Business Development at Applied Molecular Evolution, Inc. from 2002 to 2004, Associate at Vestar Capital Partners LLC from 1997 to 1998, Independent Member-Supervisory Board at MediGene AG, and Partner & Head at Life Sciences QVT Financial LP.
Education includes a doctorate from Harvard Medical School and an undergraduate degree from Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ROIVANT SCIENCES LTD. 0,24 % | 30.06.2026 | 1.748.403 ( 0,24 % ) | 61 Mio $ | 31.08.2026 |
Aktive Positionen von Keith Manchester
| Unternehmen | Position | Beginn |
|---|---|---|
| ROIVANT SCIENCES LTD. | Direktor/Vorstandsmitglied | 01.01.2014 |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology. | Portfolio Manager-Aktien | 01.01.2005 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Direktor/Vorstandsmitglied | 01.01.2014 |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Keith Manchester
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Direktor/Vorstandsmitglied | 24.02.2025 |
| MYOVANT SCIENCES LTD. | Direktor/Vorstandsmitglied | 20.09.2018 |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Direktor/Vorstandsmitglied | 01.03.2015 |
VCP I Inc
 VCP I Inc Investment ManagersFinance Vestar Capital invests in companies located in the United States. The firm targets companies operating in the fields of consumer, healthcare and business & technology services. It provides financing for buyout, MBO, carve-outs and growth capital requirements. It acquires control or makes minority investments. | Corporate Officer/Principal | 31.12.1998 |
| ROIVANT SCIENCES LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Keith Manchester
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Applied Molecular Evolution, Inc.
 Applied Molecular Evolution, Inc. BiotechnologyHealth Technology Develops and manufactures proteins & genes for commercial purposes | Health Technology |
QVT Financial LP
QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology. | Finance |
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for inflammatory diseases | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
VCP I Inc
VCP I Inc Investment ManagersFinance Vestar Capital invests in companies located in the United States. The firm targets companies operating in the fields of consumer, healthcare and business & technology services. It provides financing for buyout, MBO, carve-outs and growth capital requirements. It acquires control or makes minority investments. | Finance |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Life Sciences Qvt Financial LP | |
Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases | Health Technology |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
